The super-rapid technique in Maastricht category III donors: has it developed enough for marginal liver grafts from donors after cardiac death?

被引:28
作者
Thamara, M. [1 ]
Perera, P. R. [1 ]
机构
[1] Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham B15 2TH, W Midlands, England
关键词
donation after cardiac death; organ procurement; warm ischaemia time; ORGAN PROCUREMENT; DONATION; TRANSPLANTATION; AORTA; TIME; WITHDRAWAL; PERFUSION; LEGAL;
D O I
10.1097/MOT.0b013e3283510817
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Purpose of review Follow-up data from donors following cardiac death (DCD) liver transplants suggest an increased risk of graft failure and morbid complications, and the risk increased with grafts from marginal donors. Donor warm ischaemia (dWIT) stands out as the common aetiological factor. Aim of this review is to examine if super-rapid technique had developed sufficiently enough to improve the effects of dWIT that had been started since treatment withdrawal in category III DCD marginal donors. Recent findings The recent findings suggest limited evolvement, but these have not been contributed to reduce dWIT significantly. Evidence suggests hypoperfusion and circulatory stop occurring well before electrophysical inactivity; hence, dWIT is probably underestimated. Time spent since cardiac death to aortic cross clamp is directly linked to ischaemic complications; limited modifications to surgical technique alone have failed to make an impact on these complications. Marginal grafts generally perform worse, increasing the overall financial cost of patient management. Summary Irrespective of the speed at which aortic perfusion is instituted, the technical developments have not been able to improve outcomes/utility of marginal DCD grafts. The future of the DCD programmes should explore the means of reviving organ damage incurred during dWIT that are incorporated to the super-rapid technique of organ harvest.
引用
收藏
页码:131 / 136
页数:6
相关论文
共 36 条
[1]   Legal aspects of organ transplantation in Italy [J].
Bruzzone, P. ;
Venettoni, S. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (06) :1818-1819
[2]  
CASAVILLA A, 1995, TRANSPLANT P, V27, P710
[3]   EXPERIENCE WITH LIVER AND KIDNEY ALLOGRAFTS FROM NON-HEART-BEATING DONORS [J].
CASAVILLA, A ;
RAMIREZ, C ;
SHAPIRO, R ;
NGHIEM, D ;
MIRACLE, K ;
BRONSTHER, O ;
RANDHAWA, P ;
BROZNICK, B ;
FUNG, JJ ;
STARZL, T .
TRANSPLANTATION, 1995, 59 (02) :197-203
[4]   Similar liver transplantation survival with selected cardiac death donors and brain death donors [J].
Dubbeld, J. ;
Hoekstra, H. ;
Farid, W. ;
Ringers, J. ;
Porte, R. J. ;
Metselaar, H. J. ;
Baranski, A. G. ;
Kazemier, G. ;
van den Bere, A. P. ;
van Hoek, B. .
BRITISH JOURNAL OF SURGERY, 2010, 97 (05) :744-753
[5]   Use of a liver from donor after cardiac death: is it appropriate for the sick or the stable? [J].
Dubbeld, Jeroen ;
van Hoek, Bart ;
Ringers, Jan .
CURRENT OPINION IN ORGAN TRANSPLANTATION, 2011, 16 (02) :239-242
[6]   Biliary Complications After Liver Transplantation From Donation After Cardiac Death Donors An Analysis of Risk Factors and Long-term Outcomes From a Single Center [J].
Foley, David P. ;
Fernandez, Luis A. ;
Leverson, Glen ;
Anderson, Michael ;
Mezrich, Joshua ;
Sollinger, Hans W. ;
D'Alessandro, Anthony .
ANNALS OF SURGERY, 2011, 253 (04) :817-825
[7]   Liver transplant using donors after unexpected cardiac death:: Novel preservation protocol and acceptance criteria [J].
Fondevila, C. ;
Hessheimer, A. J. ;
Ruiz, A. ;
Calatayud, D. ;
Ferrer, J. ;
Charco, R. ;
Fuster, J. ;
Navasa, M. ;
Rimola, A. ;
Taura, P. ;
Gines, P. ;
Manyalich, M. ;
Garcia-Valdecasas, J. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (07) :1849-1855
[8]   Applicability and Results of Maastricht Type 2 Donation After Cardiac Death Liver Transplantation [J].
Fondevila, C. ;
Hessheimer, A. J. ;
Flores, E. ;
Ruiz, A. ;
Mestres, N. ;
Calatayud, D. ;
Paredes, D. ;
Rodriguez, C. ;
Fuster, J. ;
Navasa, M. ;
Rimola, A. ;
Taura, P. ;
Garcia-Valdecasas, J. C. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (01) :162-170
[9]  
Grandas OH, 2008, AM SURGEON, V74, P1198
[10]   Use of Tissue Plasminogen Activator in Liver Transplantation from Donation After Cardiac Death Donors [J].
Hashimoto, K. ;
Eghtesad, B. ;
Gunasekaran, G. ;
Fujiki, M. ;
Uso, T. D. ;
Quintini, C. ;
Aucejo, F. N. ;
Kelly, D. M. ;
Winans, C. G. ;
Vogt, D. P. ;
Parker, B. M. ;
Irefin, S. A. ;
Miller, C. M. ;
Fung, J. J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (12) :2665-2672